Sabine Hellwig
Overview
Explore the profile of Sabine Hellwig including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
2712
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shean R, Hellwig S, Saadalla A, George T, Rets A
Am J Clin Pathol
. 2025 Mar;
PMID: 40036308
Objective: Systemic mastocytosis is a hematologic malignancy characterized by clonal expansion of neoplastic mast cells. Detection of this variation is critical for screening and diagnosis, with recent guidelines emphasizing the...
2.
Rau A, Philipsen L, Frings L, Muller-Glaw P, Reisert M, Mast H, et al.
Brain
. 2025 Feb;
PMID: 39985450
Cognitive impairment is a major contributor to the burden in Parkinson's disease and dementia with Lewy bodies, both of which make up the Lewy body disease spectrum, with dementia affecting...
3.
Wiels W, Oomens J, Engelborghs S, Baeken C, von Arnim C, Boada M, et al.
JAMA Psychiatry
. 2025 Jan;
82(3):296-310.
PMID: 39841452
Importance: Depressive symptoms are associated with cognitive decline in older individuals. Uncertainty about underlying mechanisms hampers diagnostic and therapeutic efforts. This large-scale study aimed to elucidate the association between depressive...
4.
Heibel M, Urbach H, Domschke K, Hellwig S
Nervenarzt
. 2024 Dec;
96(1):89-92.
PMID: 39704793
No abstract available.
5.
Apostolova I, Hellwig S, Karimzadeh A, Klutmann S, Meyer P, Buchert R
Eur J Nucl Med Mol Imaging
. 2024 Nov;
52(4):1549-1555.
PMID: 39614909
Purpose: This study examined the impact of venlafaxine and bupropion on the detection of nigrostriatal degeneration by dopamine transporter (DAT)-SPECT. Methods: 43 patients (70.7 ± 8.6y, 44% female) with [I]FP-CIT-SPECT...
6.
Apweiler M, Saliba S, Sun L, Streyczek J, Normann C, Hellwig S, et al.
Mol Psychiatry
. 2024 May;
29(12):3779-3788.
PMID: 38796643
Pharmacological treatment of psychiatric disorders remains challenging in clinical, pharmacological, and scientific practice. Even if many different substances are established for treating different psychiatric conditions, subgroups of patients show only...
7.
Underhill H, Karsy M, Davidson C, Hellwig S, Stevenson S, Goold E, et al.
Cancer Res
. 2024 Jan;
84(7):1149-1164.
PMID: 38270917
Significance: True2 is a next-generation sequencing workflow that facilitates unbiased discovery of somatic mutations across the full range of variant allele frequencies, which could help identify residual disease vulnerabilities for...
8.
Diehl E, Mulder L, Imm C, Kegel P, Tolksdorf M, Wiegand H, et al.
Front Public Health
. 2023 Aug;
11:1186929.
PMID: 37637807
Background: Due to the SARS-CoV-2 pandemic, healthcare workers (HCWs) are experiencing tremendous levels of emotional and physical stress. Hospitals are trying to help personnel cope with work-related pressure. The aim...
9.
Hellwig S, Domschke K
Nervenarzt
. 2023 Jun;
94(7):647-654.
PMID: 37341771
Anxiety disorders are frequent, with a 12-month prevalence of 14%, tend to be chronic, and display a high comorbidity with substance abuse disorders. Anxiety and substance abuse disorders are associated...
10.
Frings L, Blazhenets G, Binder R, Bormann T, Hellwig S, Meyer P
Alzheimers Res Ther
. 2023 Jan;
15(1):11.
PMID: 36627641
Background: Left-predominant neurodegeneration of the anterior temporal lobe (ATL) and the associated syndrome termed semantic variant primary progressive aphasia (svPPA) are well characterized. Less is known about right-predominant neurodegeneration of...